Arthur S Tischler Selected Research

Pheochromocytoma

1/2020	A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+/- rats.
1/2020	Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
1/2018	Acute Hypoxia Induces Enkephalin Production and Release in an Adrenergic Cell Line Model of Neonatal Chromaffin Cell Responses to Hypoxic Stress.
11/2017	Case Report of a Prolactinoma in a Patient With a Novel MAX Mutation and Bilateral Pheochromocytomas.
7/2017	Max Schottelius: Pioneer in Pheochromocytoma.
6/2015	SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).
1/2015	Potential therapeutic target for malignant paragangliomas: ATP synthase on the surface of paraganglioma cells.
1/2014	Cytocidal activities of topoisomerase 1 inhibitors and 5-azacytidine against pheochromocytoma/paraganglioma cells in primary human tumor cultures and mouse cell lines.
4/2013	Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
2/2013	Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arthur S Tischler Research Topics

Disease

44	Neoplasms (Cancer) 03/2023 - 01/2003
31	Pheochromocytoma 01/2020 - 07/2002
13	Paraganglioma (Paragangliomas) 01/2020 - 02/2011
7	Neoplasm Metastasis (Metastasis) 03/2014 - 02/2007
5	Hypoxia (Hypoxemia) 01/2018 - 10/2002
4	Hyperplasia 03/2023 - 01/2003
3	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2020 - 10/2004
3	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2020 - 07/2002
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2005 - 09/2004
3	Neurofibromatoses (Neurofibromatosis) 10/2002 - 07/2002
2	Adenoma (Adenomas) 08/2021 - 01/2003
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 02/2005 - 10/2004
1	Atrophy 03/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2018
1	Islet cell tumor syndrome 12/2017
1	Primary Hyperparathyroidism 11/2017
1	Polycythemia (Erythrocytosis) 12/2016
1	Somatostatinoma 12/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2013
1	Disease Progression 01/2013
1	Carcinogenesis 01/2013
1	Extra-Adrenal Paraganglioma (Paraganglioma, Extra Adrenal) 03/2012
1	Pituitary Neoplasms (Pituitary Adenoma) 09/2011

Drug/Important Bio-Agent (IBA)

11	Succinate Dehydrogenase (Fumarate Reductase)IBA 08/2021 - 07/2005
10	CatecholaminesIBA 07/2017 - 07/2002
9	Proteins (Proteins, Gene)FDA Link 12/2017 - 01/2003
6	Adrenergic Agents (Adrenergic Drugs)IBA 01/2018 - 10/2002
5	EnzymesIBA 01/2020 - 07/2002
4	Biomarkers (Surrogate Marker)IBA 03/2023 - 03/2012
4	Chromogranin AIBA 09/2011 - 01/2003
3	SynaptophysinIBA 06/2019 - 10/2004
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2014 - 01/2003
3	Proto-Oncogene Proteins c-retIBA 01/2008 - 07/2002
2	4-carboxyphenylglyoxalIBA 10/2022 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 10/2002
2	Glucagon (Glukagon)FDA Link 12/2021 - 08/2021
2	Oxygen (Dioxygen)IBA 11/2018 - 01/2018
2	Myc associated factor XIBA 12/2017 - 11/2017
2	endothelial PAS domain-containing protein 1IBA 12/2016 - 05/2013
2	Adenosine Triphosphate (ATP)IBA 01/2015 - 02/2013
2	LuciferasesIBA 01/2014 - 03/2012
2	DNA (Deoxyribonucleic Acid)IBA 05/2013 - 02/2005
2	Messenger RNA (mRNA)IBA 01/2012 - 01/2003
2	ChromograninsIBA 09/2011 - 10/2004
2	Phosphopyruvate Hydratase (Enolase)IBA 09/2011 - 10/2004
2	Phenylethanolamine N-MethyltransferaseIBA 01/2008 - 01/2003
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2008 - 01/2003
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 02/2005 - 07/2002
2	Chromogranin BIBA 10/2004 - 01/2003
1	Hormones (Hormone)IBA 03/2023
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 12/2021
1	Keratins (Keratin)IBA 12/2021
1	SaltsIBA 08/2021
1	ChromatinIBA 08/2021
1	PolyaminesIBA 01/2020
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2020
1	ProteomeIBA 06/2019
1	CD163 antigenIBA 06/2019
1	AntioxidantsIBA 11/2018
1	OMS 2017IBA 01/2018
1	EnkephalinsIBA 01/2018
1	fluorodopa F 18IBA 12/2017
1	Parathyroid Hormone (Parathormone)IBA 11/2017
1	ChromatesIBA 07/2017
1	Fixatives (Pickling Agents)IBA 07/2017
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 12/2016
1	Anesthetics (Anesthetic Agents)IBA 07/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	AcidsIBA 01/2015
1	AngiostatinsIBA 01/2015
1	AntibodiesIBA 01/2015
1	AurovertinsIBA 01/2015
1	ResveratrolIBA 01/2015
1	3-methoxytyramine (methoxytyramine)IBA 03/2014
1	Dopamine (Intropin)FDA LinkGeneric 03/2014
1	CamptothecinIBA 01/2014
1	Azacitidine (5 Azacytidine)FDA Link 01/2014
1	A-Form DNA (A-DNA)IBA 01/2014
1	Topoisomerase I InhibitorsIBA 01/2014
1	ParaffinIBA 05/2013
1	Formaldehyde (Formol)FDA Link 05/2013
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 02/2013
1	TOR Serine-Threonine KinasesIBA 02/2013
1	Mechanistic Target of Rapamycin Complex 2IBA 02/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 02/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 03/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2012
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 01/2012
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2011
1	ProlactinIBA 09/2011

Therapy/Procedure

8	Therapeutics 03/2023 - 01/2006
2	Thyroidectomy 01/2020 - 12/2005
1	Precision Medicine 10/2022
1	Ligation 08/2021
1	Mastoidectomy 08/2021
1	Liver Transplantation 07/2015
1	Drug Therapy (Chemotherapy) 01/2014